Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Cormedix Inc (CRMD)

Cormedix Inc (CRMD)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 176,338
  • Shares Outstanding, K 38,086
  • Annual Sales, $ 240 K
  • Annual Income, $ -22,030 K
  • 60-Month Beta 2.43
  • Price/Sales 881.96
  • Price/Cash Flow N/A
  • Price/Book 2.54
Trade CRMD with:

Options Overview Details

View History
  • Implied Volatility 84.20% ( +6.05%)
  • Historical Volatility 45.47%
  • IV Percentile 54%
  • IV Rank 14.21%
  • IV High 225.94% on 02/26/21
  • IV Low 60.72% on 12/23/21
  • Put/Call Vol Ratio 0.00
  • Today's Volume 11
  • Volume Avg (30-Day) 60
  • Put/Call OI Ratio 0.00
  • Today's Open Interest 227
  • Open Int (30-Day) 951

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/21
See More
  • Average Estimate -0.22
  • Number of Estimates 1
  • High Estimate -0.22
  • Low Estimate -0.22
  • Prior Year -0.19
  • Growth Rate Est. (year over year) -15.79%

Price Performance

See More
Period Period Low Period High Performance
1-Month
4.30 +5.58%
on 12/29/21
5.03 -9.74%
on 12/23/21
-0.20 (-4.22%)
since 12/17/21
3-Month
4.30 +5.58%
on 12/29/21
5.88 -22.79%
on 11/02/21
-0.27 (-5.61%)
since 10/18/21
52-Week
4.30 +5.58%
on 12/29/21
18.80 -75.85%
on 02/19/21
-4.30 (-48.64%)
since 01/15/21

Most Recent Stories

More News
CorMedix Inc. Announces Abstracts at Upcoming Conferences Showing Patient Outcomes and Economic Burden of CRBSI

BERKELEY HEIGHTS, N.J., Oct. 20, 2021 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and...

CRMD : 4.55 (-1.73%)
CorMedix Inc. Announces Executive Leadership Changes

BERKELEY HEIGHTS, N.J., Oct. 04, 2021 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and...

CRMD : 4.55 (-1.73%)
LAWSUITS FILED AGAINST CRMD, ATVI and YALA - Jakubowitz Law Pursues Shareholders Claims

NEW YORK, NY / ACCESSWIRE / September 20, 2021 / Jakubowitz Law announces that securities fraud class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies...

CRMD : 4.55 (-1.73%)
ATVI : 82.13 (+25.60%)
YALA : 6.34 (-3.06%)
DEADLINE ALERT for COIN and CRMD: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders

LOS ANGELES, Sept. 20, 2021 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded...

COIN : 223.57 (-2.81%)
CRMD : 4.55 (-1.73%)
SHAREHOLDER ALERT: CRMD SLQT SPPI: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines

NEW YORK, NY / ACCESSWIRE / September 20, 2021 / The Law Offices of Vincent Wong announce that class actions have commenced on behalf of certain shareholders in the following companies. If you suffered...

CRMD : 4.55 (-1.73%)
SLQT : 7.82 (-5.44%)
SPPI : 1.0850 (-3.98%)
The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of COIN, CRMD and HNST

NEW YORK, NY / ACCESSWIRE / September 20, 2021 / The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. There is no cost to participate...

COIN : 223.57 (-2.81%)
CRMD : 4.55 (-1.73%)
HNST : 6.61 (-3.22%)
CLASS ACTION UPDATE for CRMD, SAVA and HNST: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders

NEW YORK, NY / ACCESSWIRE / September 20, 2021 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders...

CRMD : 4.55 (-1.73%)
SAVA : 42.05 (-8.35%)
HNST : 6.61 (-3.22%)
CRMD FINAL DEADLINE TOMORROW: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages CorMedix Inc. Investors with Losses to Secure Counsel Before Important September 20 Deadline in Securities Class Action – CRMD

NEW YORK, Sept. 19, 2021 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of CorMedix Inc. (NASDAQ: CRMD) between July 8, 2020 and May...

CRMD : 4.55 (-1.73%)
The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of CRMD, ITRM and PHG

NEW YORK, NY / ACCESSWIRE / September 19, 2021 / The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. There is no cost to participate...

CRMD : 4.55 (-1.73%)
ITRM : 0.3843 (-1.46%)
PHG : 33.54 (-2.47%)
DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against CorMedix Inc. and Encourages Investors to Contact the Firm

Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, reminds investors that a class action lawsuit has been filed against CorMedix Inc. (“CorMedix” or the “Company”)...

CRMD : 4.55 (-1.73%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

CorMedix Inc. is a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases. The Company is focused on developing its lead product Defencath (TM), a novel, antibacterial and antifungal solution designed...

See More

Key Turning Points

3rd Resistance Point 4.85
2nd Resistance Point 4.75
1st Resistance Point 4.69
Last Price 4.55
1st Support Level 4.54
2nd Support Level 4.44
3rd Support Level 4.38

See More

52-Week High 18.80
Fibonacci 61.8% 13.26
Fibonacci 50% 11.55
Fibonacci 38.2% 9.84
Last Price 4.55
52-Week Low 4.30

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar